Persistent Asset Partners’s Terns Pharmaceuticals TERN Stock Holding History

Persistent Asset Partners’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-147	Closed	-$464K	–	468
2025 Q4	$464K	Sell	147 -373	-72%	-$8.62K	0.21%	137
2025 Q3	$174K	Buy	520 +147	+39%	+$939	0.12%	136
2025 Q2	$35.3K	Buy	+373	New	+$1.17K	0.03%	155

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Persistent Asset Partners's TERN Position: Q2 2026 in Review

Persistent Asset Partners sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 45,953 shares — an estimated $2.42M sold.

Persistent Asset Partners first reported a position in TERN in Q4 2024 and held it in 6 quarters. The position peaked at $4.59M in Q4 2025. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Persistent Asset Partners reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Persistent Asset Partners sold 45,953 Terns Pharmaceuticals shares in Q2 2026, an estimated $2.42M.
Persistent Asset Partners first reported a position in Terns Pharmaceuticals in Q4 2024 and held it in 6 quarters.
Persistent Asset Partners's Terns Pharmaceuticals position peaked at $4.59M in Q4 2025.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.